HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert W Keane Selected Research

I-kappa B Kinase

10/2006Therapeutic hypothermia modulates TNFR1 signaling in the traumatized brain via early transient activation of the JNK pathway and suppression of XIAP cleavage.
12/2004Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert W Keane Research Topics

Disease

25Inflammation (Inflammations)
01/2024 - 12/2004
20Traumatic Brain Injuries (Traumatic Brain Injury)
01/2024 - 12/2004
12Spinal Cord Injuries (Spinal Cord Injury)
01/2018 - 09/2002
7Alzheimer Disease (Alzheimer's Disease)
01/2024 - 04/2014
7Wounds and Injuries (Trauma)
01/2023 - 03/2008
6Neuroinflammatory Diseases
01/2024 - 04/2014
6Stroke (Strokes)
10/2022 - 03/2009
5Brain Injuries (Brain Injury)
01/2024 - 01/2016
5Multiple Sclerosis
09/2020 - 01/2016
4Infections
01/2023 - 05/2014
4Lung Injury
01/2021 - 01/2017
3Hyperoxia
05/2024 - 01/2017
3Acute Lung Injury
01/2024 - 01/2018
3Cognitive Dysfunction
06/2020 - 12/2011
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2020 - 01/2016
3Porcine Reproductive and Respiratory Syndrome (PRRS)
08/2014 - 07/2013
3Contusions
03/2012 - 09/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2023 - 02/2012
2COVID-19
01/2023 - 01/2020
2Disease Progression
05/2020 - 01/2018
2Brain Ischemia (Cerebral Ischemia)
01/2018 - 03/2009
2Melanoma (Melanoma, Malignant)
04/2014 - 03/2012
2Ischemia
01/2013 - 03/2009
2Hypothermia
10/2012 - 10/2006
1Eye Injuries (Eye Injury)
05/2024
1Dementia (Dementias)
01/2024
1Cardiovascular Diseases (Cardiovascular Disease)
01/2024
1Parkinson Disease (Parkinson's Disease)
06/2023
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2023
1Ischemic Stroke
10/2022
1Lupus Nephritis
01/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Alcoholic Fatty Liver
11/2020
1Liver Diseases (Liver Disease)
11/2020
1Psoriatic Arthritis
01/2020
1Ventilator-Induced Lung Injury
01/2020
1Central Nervous System Diseases (CNS Diseases)
01/2020
1Disseminated Intravascular Coagulation
01/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020
1Vascular Remodeling
01/2017
1Bronchopulmonary Dysplasia
01/2017

Drug/Important Bio-Agent (IBA)

46InflammasomesIBA
01/2024 - 03/2008
27Proteins (Proteins, Gene)FDA Link
05/2024 - 10/2006
12Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2018
12CytokinesIBA
01/2023 - 03/2008
8Interleukin-18 (Interleukin 18)IBA
06/2023 - 03/2009
8InterleukinsIBA
01/2023 - 03/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 12/2004
4NLR ProteinsIBA
01/2016 - 07/2013
3Monoclonal AntibodiesIBA
05/2024 - 01/2020
3Type I Tumor Necrosis Factor ReceptorsIBA
01/2020 - 10/2006
3Pattern Recognition ReceptorsIBA
08/2014 - 07/2013
3CaspasesIBA
02/2012 - 09/2002
3LigandsIBA
05/2007 - 12/2004
2Multiprotein ComplexesIBA
01/2023 - 01/2016
2Interleukin-6 (Interleukin 6)IBA
10/2022 - 01/2020
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2021 - 01/2020
2Enoxaparin (Lovenox)FDA LinkGeneric
01/2021 - 01/2020
2NucleotidesIBA
01/2016 - 12/2011
2Interleukin-1 (Interleukin 1)IBA
01/2016 - 08/2011
2DNA (Deoxyribonucleic Acid)IBA
04/2014 - 03/2014
2Probenecid (Benemid)FDA LinkGeneric
04/2014 - 12/2012
2Adenosine Triphosphate (ATP)IBA
03/2014 - 07/2013
2Peptides (Polypeptides)IBA
09/2013 - 09/2002
2X-Linked Inhibitor of Apoptosis ProteinIBA
07/2009 - 10/2006
2Neutralizing AntibodiesIBA
07/2009 - 03/2009
2Interleukin-1beta (Interleukin 1 beta)IBA
07/2009 - 03/2008
2NF-kappa B (NF-kB)IBA
10/2006 - 12/2004
2I-kappa B KinaseIBA
10/2006 - 12/2004
1Oxygen (Dioxygen)IBA
05/2024
1Retinaldehyde (Retinal)IBA
05/2024
1Protein Isoforms (Isoforms)IBA
05/2024
1Conditioned Culture MediaIBA
01/2024
1NeurograninIBA
01/2024
1tau Proteins (tau Protein)IBA
01/2024
1Complement System Proteins (Complement)IBA
09/2023
1SynucleinsIBA
06/2023
1Interleukin-13IBA
10/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022
1Vascular Endothelial Growth Factor CIBA
10/2022
1Interleukin-16 (Interleukin 16)IBA
10/2022
1Interleukin-2 (IL2)IBA
10/2022
1Interleukin-4 (Interleukin 4)IBA
10/2022
1Interleukin-8 (Interleukin 8)IBA
10/2022
1Galectin 3 (LGALS3)IBA
11/2020
1Dacarbazine (DIC)FDA LinkGeneric
01/2020
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2020
1N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA
01/2019
1interleukin-1beta-converting enzyme inhibitorIBA
01/2019
1salicylhydroxamic acid (SHAM)IBA
01/2018
1NSC 23766IBA
01/2017
1Saline SolutionIBA
01/2017
1Caspase 1 (ICE Protease)IBA
01/2016
1Pathogen-Associated Molecular Pattern MoleculesIBA
08/2014
1C-Type Lectins (C-Type Lectin)IBA
08/2014

Therapy/Procedure

4Therapeutics
01/2020 - 12/2012
2Intraperitoneal Injections
01/2019 - 01/2017
1Microelectrodes
01/2023
1Electrodes (Electrode)
01/2023
1Artificial Respiration (Mechanical Ventilation)
01/2020